🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Olivia M Dong

RTI Health Solutions

ORCID: 0000-0003-2241-5402

Pharmacology, Toxicology and PharmaceuticsEconomics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma”.

Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma

Value in Health(2021)10.1016/j.jval.2021.09.017

N/A

0.416DataRank · unranked

15 citations

Pradeep Poonnen, David Winski, Shelby D. Reed, Vishal Vashistha, Jill Bates +3 more

Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network

Journal of Personalized Medicine(2021)10.3390/jpm11070647

N/A

0DataRank · unranked

27 citations

Olivia M Dong, Megan C. Roberts, Paul Dexter, Amanda R. Elsey, Geoffrey S. Ginsburg +11 more

Cost-effectiveness ofCYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes

European Heart Journal - Quality of Care and Clinical Outcomes(2022)10.1093/ehjqcco/qcac031

N/A

0DataRank · unranked

14 citations

Kevin A. Friede, Catherine Chanfreau‐Coffinier, Deepak Voora, Olivia M Dong